Insmed Incorporated (0JAV.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:46PM BST
| Previous close | 26.43 |
| Open | 26.72 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 25.64 - 26.72 |
| 52-week range | 16.58 - 31.99 |
| Volume | |
| Avg. volume | 1,364 |
| Market cap | 23.078M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript May 9, 2024 Insmed Incorporated beats earnings expectations. Reported EPS is $-1.05817, expectations were $-1.21. Insmed Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name […]
- GuruFocus.com
Insmed Inc (INSM) Reports Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows Amidst Clinical ...
A Detailed Look at Insmed's Financial Performance and Strategic Clinical Updates
- Zacks
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
© 2024 Yahoo. All rights reserved.